-
1
-
-
0030737674
-
The role of dopamine agonists in early Parkinson's disease
-
Walts RL. The role of dopamine agonists in early Parkinson's disease. Neurology 1997;49(suppl 1):S34-48.
-
(1997)
Neurology
, vol.49
, Issue.SUPPL. 1
-
-
Walts, R.L.1
-
3
-
-
18244411921
-
Retroperitoneal fibrosis caused by treatment with pergolide in a patient with Parkinson's disease
-
Kunkler RB, Osborn DE, Abbott RJ. Retroperitoneal fibrosis caused by treatment with pergolide in a patient with Parkinson's disease. Br J Urol 1998;82:147.
-
(1998)
Br J Urol
, vol.82
, pp. 147
-
-
Kunkler, R.B.1
Osborn, D.E.2
Abbott, R.J.3
-
4
-
-
0022521699
-
Retroperitoneal fibrosis and treatment of Parkinson's disease with high doses of bromocriptine
-
Demonet JF, Rostin M, Dueymes JM, Ioualalen A, Montastruc JL, Rascol A. Retroperitoneal fibrosis and treatment of Parkinson's disease with high doses of bromocriptine. Clin Neuropharmacol 1986;9:200-1.
-
(1986)
Clin Neuropharmacol
, vol.9
, pp. 200-201
-
-
Demonet, J.F.1
Rostin, M.2
Dueymes, J.M.3
Ioualalen, A.4
Montastruc, J.L.5
Rascol, A.6
-
5
-
-
0022527489
-
Retroperitoneal fibrosis and bromocriptine
-
Bowler JV, Ormerod IE, Legg NJ. Retroperitoneal fibrosis and bromocriptine. Lancet 1986;2:466.
-
(1986)
Lancet
, vol.2
, pp. 466
-
-
Bowler, J.V.1
Ormerod, I.E.2
Legg, N.J.3
-
6
-
-
0024506456
-
Retroperitoneal fibrosis in a patient with macroprolactinoma treated with bromocriptine
-
Herzog A, Minne H, Ziegler R. Retroperitoneal fibrosis in a patient with macroprolactinoma treated with bromocriptine. Br Med J 1989;298:1315.
-
(1989)
Br Med J
, vol.298
, pp. 1315
-
-
Herzog, A.1
Minne, H.2
Ziegler, R.3
-
7
-
-
0024374109
-
Bromocriptine-associated retroperitoneal fibrosis presenting with testicular retraction
-
Murphy F, Pickard RS. Bromocriptine-associated retroperitoneal fibrosis presenting with testicular retraction. Br J Urol 1989;64:318-19.
-
(1989)
Br J Urol
, vol.64
, pp. 318-319
-
-
Murphy, F.1
Pickard, R.S.2
-
8
-
-
0026110115
-
Retroperitoneal fibrosis, skin and pleuropulmonary changes associated with bromocriptine therapy
-
Hely MA, Morris JGL, Lawrence S, Jeremy R, Genge S. Retroperitoneal fibrosis, skin and pleuropulmonary changes associated with bromocriptine therapy. Aust NZ J Med 1991;21:82-4.
-
(1991)
Aust NZ J Med
, vol.21
, pp. 82-84
-
-
Hely, M.A.1
Morris, J.G.L.2
Lawrence, S.3
Jeremy, R.4
Genge, S.5
-
9
-
-
0019970271
-
Ergotamine as a possible cause of retroperitoneal fibrosis
-
Lepage-Savary D, Vallieres A. Ergotamine as a possible cause of retroperitoneal fibrosis. Clin Pharm 1982;1:179-80.
-
(1982)
Clin Pharm
, vol.1
, pp. 179-180
-
-
Lepage-Savary, D.1
Vallieres, A.2
-
11
-
-
0013922084
-
Reversible retroperitoneal fibrosis with ureteral obstruction associated with ingestion of Sansert
-
Weiss JM, Hinman F. Reversible retroperitoneal fibrosis with ureteral obstruction associated with ingestion of Sansert. J Urol 1966;95:771-5.
-
(1966)
J Urol
, vol.95
, pp. 771-775
-
-
Weiss, J.M.1
Hinman, F.2
-
12
-
-
0014433361
-
Silent retroperitoneal fibrosis associated with methysergide therapy
-
Elkind AH, Friedman AP, Bachman A, Siegelman SS, Sacks OW. Silent retroperitoneal fibrosis associated with methysergide therapy. JAMA 1968;206:1041-4.
-
(1968)
JAMA
, vol.206
, pp. 1041-1044
-
-
Elkind, A.H.1
Friedman, A.P.2
Bachman, A.3
Siegelman, S.S.4
Sacks, O.W.5
-
13
-
-
0014360386
-
Methysergide, retroperitoneal fibrosis and rectosigmoid stricture
-
Gelford GJ, Cromwell DK. Methysergide, retroperitoneal fibrosis and rectosigmoid stricture. Am J Roentgenol Radium Ther 1968;104:566-70.
-
(1968)
Am J Roentgenol Radium Ther
, vol.104
, pp. 566-570
-
-
Gelford, G.J.1
Cromwell, D.K.2
-
15
-
-
0014829788
-
Retroperitoneal fibrosis in two patients previously exposed to LSD
-
Aptekar RG, Mitchinson MJ. Retroperitoneal fibrosis in two patients previously exposed to LSD. California Med 1970;113:77-9.
-
(1970)
California Med
, vol.113
, pp. 77-79
-
-
Aptekar, R.G.1
Mitchinson, M.J.2
|